What is NAD+ and Why Does it Matter?

⏳ Longevity & Anti-Aging ⏱ 12 min read 🎓 Beginner

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. NAD+ supplementation is not FDA-approved as a treatment for any disease or medical condition. Always consult a licensed healthcare provider before starting any supplement protocol.

If you have spent any time in longevity circles — following researchers, listening to podcasts, reading about anti-aging science — you will have encountered NAD+. It appears on supplement labels, in academic papers, in discussions of sirtuins and cellular aging and mitochondrial function. The claims made about it range from sensible to extraordinary.

This guide cuts through the noise. NAD+ is genuinely important — it plays a central role in some of the most fundamental processes in cellular biology, and its decline with age is real and well-documented. What it can and cannot do when supplemented in humans is a different and more complicated question, and that distinction matters enormously for anyone trying to make intelligent decisions in this space.

Key Takeaways

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell — essential for energy metabolism, DNA repair, and the regulation of longevity-associated enzymes called sirtuins.
Plasma NAD+ levels decline roughly 60% from early to late adulthood. Documented declines have been measured in human skin, liver, brain, and muscle tissue.
Three enzyme families consume and deplete NAD+ with age: PARPs (DNA repair), CD38 (immunity and inflammation), and sirtuins themselves (gene regulation).
NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are the most studied NAD+ precursor supplements. Both reliably raise blood NAD+ in humans — the clinical question is whether that elevation translates to meaningful health benefits.
Human evidence for functional longevity benefits (beyond NAD+ elevation itself) is preliminary — some promising signals in metabolic health, cognition, and muscle function, but not yet at the level of established outcomes.
Exercise is the most consistently effective non-supplemental way to raise NAD+ levels — a finding that should inform how supplements are positioned relative to lifestyle.

What NAD+ Actually Is

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme — a small molecule that works alongside enzymes to enable biochemical reactions — found in every living cell. It exists in two forms: NAD+ (oxidised) and NADH (reduced), and it shuttles electrons between these two forms as part of the fundamental chemistry of cellular metabolism.

The reason NAD+ has attracted such intense longevity research interest is that it sits at the intersection of several cellular functions that are central to how we age: energy production, DNA repair, gene regulation, and the control of inflammation. It is, in a real sense, a master regulator of cellular health — and the fact that it declines significantly with age makes it an obvious target for intervention.^[1]

Energy Metabolism NAD+ is the central carrier of electrons in glycolysis, the TCA cycle (Krebs cycle), and the mitochondrial electron transport chain — the three interconnected processes that convert food into cellular energy (ATP). Without adequate NAD+, energy production is impaired at the most fundamental level.

DNA Repair PARP enzymes (poly ADP-ribose polymerases) use NAD+ as a substrate to repair damaged DNA. Every time a strand break occurs — from UV radiation, oxidative stress, or normal replication errors — PARP activation consumes NAD+. As DNA damage accumulates with age, PARP activation increases and NAD+ depletion accelerates.

Sirtuin Activation Sirtuins are a family of NAD+-dependent enzymes often described as longevity regulators. They deacetylate proteins involved in gene expression, DNA repair, mitochondrial function, and metabolic regulation. Critically, sirtuins can only function when NAD+ is available — when NAD+ drops, sirtuin activity falls with it.

Cellular Communication NAD+ is converted to signalling molecules including cADPR and NAADP that regulate calcium signalling and cellular communication. CD38, an enzyme involved in immune function, consumes NAD+ to produce these messengers — with age-related increases in CD38 activity contributing to the NAD+ decline.

Gene Expression Regulation Through sirtuin activity, NAD+ levels influence which genes are expressed and which are silenced. SIRT1 in particular targets NF-κB — the master regulator of inflammation — suppressing it when NAD+ is adequate and allowing chronic inflammatory signalling when NAD+ is depleted.

Mitochondrial Function Adequate NAD+ is essential for mitochondrial biogenesis (the production of new mitochondria) via the PGC-1α pathway. Age-related NAD+ decline is directly linked to mitochondrial dysfunction — fewer, less efficient mitochondria producing less energy with more oxidative damage as byproduct.

How Much NAD+ Declines with Age

The age-related NAD+ decline is one of the best-documented aspects of the longevity biology. Plasma NAD+ concentrations drop roughly 60% from early to late adulthood — a substantial reduction with consequences across virtually every tissue type.^[2]

Approximate NAD+ Levels Relative to Peak (Early Adulthood = 100%)

20s

~100% — Peak NAD+ availability

Baseline / reference

40s

~75–80% remaining

Early decline begins

60s

~50–60% remaining

Measurable functional decline

70s+

~40% remaining

~60% below peak

Declines documented in human skin, liver, brain, and muscle tissue. The rate of decline is not uniform across individuals or tissue types. Figures represent approximate averages from published tissue studies.

It is worth noting that the NAD+ decline is not uniform across all human tissues — some tissues show steeper declines than others, and individual variation is significant. This is one reason why some researchers are cautious about assuming that a single NAD+ supplement protocol will produce identical benefits across different individuals and tissues.

Why NAD+ Declines: The Three Drains

Understanding the decline requires understanding where NAD+ goes. Three enzyme families are primarily responsible for NAD+ consumption, and all three become more active with age — creating a progressive drain that outpaces the body's ability to restore NAD+ through normal biosynthesis.

PARPs — DNA Repair

PARP enzymes consume NAD+ to repair DNA strand breaks. As DNA damage accumulates with age (from oxidative stress, UV, replication errors), PARP activity increases. Each repair event consumes multiple NAD+ molecules. This is sometimes called the "PARP paradox" — the very mechanism that keeps us healthy by repairing DNA is simultaneously depleting the NAD+ needed for everything else.

CD38 — Immune Activation

CD38 is an enzyme that converts NAD+ into signalling molecules and whose expression increases significantly with age and inflammation. A landmark 2016 Cell Metabolism paper by Camacho-Pereira et al. identified CD38 as a primary driver of the age-related NAD+ decline — showing that CD38 knockout mice maintained youthful NAD+ levels and metabolic function. Chronic low-grade inflammation ("inflammaging") drives CD38 expression, creating a vicious cycle: low NAD+ → more inflammation → more CD38 → lower NAD+.

Sirtuins — Longevity Regulation

Sirtuins consume NAD+ to perform their deacetylase functions. The irony is that the same enzymes that make NAD+ valuable for longevity are themselves contributors to its depletion. As NAD+ falls with age, sirtuin activity falls with it — a negative feedback loop that compounds the decline.

NAMPT Decline — Reduced Production

The problem is not only increased consumption — production also declines. NAMPT (nicotinamide phosphoribosyltransferase) is the rate-limiting enzyme in the NAD+ salvage pathway, the dominant route by which cells recycle and produce NAD+. Oxidative stress and chronic inflammation directly suppress NAMPT activity, reducing the body's capacity to replenish what the drains consume.

Sirtuins: The Longevity Enzymes at the Centre of This

Sirtuins deserve specific attention because they are the primary mechanism through which NAD+ connects to longevity biology. There are seven mammalian sirtuins (SIRT1–7), each located in different cellular compartments and performing different regulatory functions.

The Seven Sirtuins — What They Do

SIRT1

Nucleus

Gene expression, inflammation suppression (NF-κB), stress resistance, metabolic regulation

SIRT2

Cytoplasm

Cell cycle regulation, neurodegeneration protection, microtubule stability

SIRT3

Mitochondria

Mitochondrial metabolism, oxidative stress management, ATP production

SIRT4

Mitochondria

Amino acid metabolism, insulin secretion regulation, mitochondrial integrity

SIRT5

Mitochondria

Metabolic enzyme regulation, ammonia detoxification, fatty acid oxidation

SIRT6

Nucleus

DNA repair, telomere maintenance, metabolic regulation, inflammation

SIRT7 (nucleolus — rRNA production, DNA damage response) is not shown above for space. Sirtuin lifespan extension is well-documented in yeast, worms, and flies. Human translational evidence is promising but more limited.^[3]

NR and NMN: The Two Main NAD+ Precursors

Direct NAD+ supplementation is not effective — the molecule is unstable and cannot cross cell membranes easily. The practical approach is to supplement with NAD+ precursors that the body converts into NAD+ intracellularly. Two precursors have dominated research and the supplement market: NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide).

NR — Nicotinamide Riboside

Classification

Vitamin B3 family member; found in small amounts in milk and yeast

Route to NAD+

NR → NMN → NAD+ (two-step conversion)

Cell entry

Enters cells relatively easily via specific transporters; must be converted to NMN before NAD+ production

Human evidence

Most human RCT data; reliably raises blood NAD+; functional benefits in inflammation, cognition under investigation

Notable study

NR in older adults with mild cognitive impairment — improved cognition markers in some measures (GeroScience, 2024)

Typical dose

250–1000mg/day

NMN — Nicotinamide Mononucleotide

Classification

Found naturally in trace amounts in edamame, broccoli, and other foods

Route to NAD+

NMN → NAD+ (one-step conversion — more direct)

Cell entry

Larger molecule with phosphate group; less easily absorbed — uses specific transporter (Slc12a8) for intestinal uptake

Human evidence

Growing body of RCTs; reliably raises blood NAD+; improved insulin sensitivity in postmenopausal women; improved walking speed and sleep in older adults

Notable study

NMN supplementation improved walking speed and sleep quality in older adults (GeroScience, 2024)

Typical dose

250–1000mg/day

What the Human Evidence Actually Shows

This is where the conversation shifts from established biology to honest assessment of clinical evidence. The gap between what NAD+ does in the cell and what supplementing with its precursors demonstrably does in humans is real and important.

Outcome	Evidence Level	Key Findings
Blood NAD+ elevation	Strong — consistent across multiple RCTs	Both NR and NMN reliably and substantially increase blood/plasma NAD+ in humans at standard doses. This is the most consistently proven effect.
Metabolic health / insulin sensitivity	Moderate — signals in specific populations	NMN improved insulin sensitivity in postmenopausal women. NR improved metabolic markers in some obese populations. Effects appear sex-specific and population-specific.
Muscle function	Moderate — emerging signals	NMN supplementation improved walking speed in older adults (GeroScience 2024). A 2025 systematic review found modest benefits for skeletal muscle mass and function with NMN/NR in older adults.
Cognitive function	Preliminary — early trials	A 2024 GeroScience RCT showed NR supplementation improved some cognitive markers in older adults with mild cognitive impairment. Trial in Alzheimer's patients showed promising signals. Larger trials ongoing.
Inflammation	Moderate — inflammatory marker reduction	NR supplementation reduced pro-inflammatory cytokines in older adults and in NAFLD patients. A 2024 Nature npj Aging trial showed reduced IL-2 and shift toward younger IgG glycosylation profile.
Cardiovascular outcomes	Preliminary — trials ongoing	Heart failure trial (250mg NR) underway. No completed large cardiovascular RCTs yet. Mechanistic rationale is strong via mitochondrial and inflammatory pathways.
Lifespan extension (humans)	Unknown — not studied	Lifespan extension is well-documented in yeast, worms, and flies. No human lifespan data exists or could practically be collected in current trial timelines.

The Honest Summary

Supplementing with NR or NMN reliably raises NAD+ in the blood. The downstream question — whether raising blood NAD+ translates into meaningfully improved tissue function, slowed aging processes, or better health outcomes in humans — has more preliminary than established answers. The animal data is compelling and the mechanistic reasoning is sound. The human clinical evidence is early but accumulating, with the strongest signals in metabolic health, muscle function in older adults, and inflammation. Lifespan extension in humans remains, necessarily, unproven.

How to Raise NAD+ — Not Just with Supplements

One of the most important — and frequently omitted — pieces of context in discussions of NAD+ supplementation is that lifestyle factors raise NAD+ meaningfully, and in some studies more consistently than supplements in younger or otherwise healthy individuals.

Strong Evidence

Exercise

Acute exercise consistently raises NAD+ levels in peripheral blood mononuclear cells. Resistance training increases skeletal muscle NAD+ concentrations and NAMPT protein levels — the very enzyme whose decline drives age-related NAD+ depletion. Aerobic exercise reverses age-related decline in NAD+ salvage capacity in human muscle. Exercise is the most robustly evidenced way to maintain NAD+ status.

Strong Evidence

Caloric Restriction / Fasting

Caloric restriction and intermittent fasting raise NAD+ levels by reducing the metabolic load on cells and increasing NAMPT activity. The NAD+-sirtuin pathway is one of the primary mechanisms through which caloric restriction extends lifespan in animal models — a finding that is well-replicated across species.

Moderate Evidence

NR Supplementation

Reliably raises blood NAD+ in humans. Functional benefit signals in inflammation, cognition, and metabolic health. More clinical data than NMN at present. Safe and well-tolerated at doses up to 2,000mg/day in studied populations.

Moderate Evidence

NMN Supplementation

Reliably raises blood NAD+. Stronger metabolic signals in some populations (postmenopausal women, older adults). Direct precursor to NAD+. Walking speed and sleep quality improvements in older adult RCT (GeroScience 2024). Growing evidence base.

Where NAD+ Fits in a Longevity Framework

NAD+ is not a cure for aging. It is one component of the biological machinery that determines how well cells function as they age — and it is a component whose decline is real, whose mechanisms are well-understood, and for which restoring levels is a scientifically coherent intervention.

The most intellectually honest framing of NAD+ supplementation in 2026 is: there is strong mechanistic and animal evidence, growing human evidence for specific functional benefits, and insufficient evidence for longevity claims. For most people reading this, the question is not whether NAD+ supplementation will extend their lifespan — that cannot be answered — but whether addressing a documented age-related decline in a molecule central to energy, DNA repair, and inflammation makes sense as part of a broader approach to healthspan.^[4]

The answer to that question is more clearly yes than for many other longevity interventions — which is why NAD+ has moved from research curiosity to mainstream clinical conversation in the space of a decade.

Interested in a longevity protocol that includes NAD+ optimisation?

Our free quiz helps you think through your goals before speaking with a clinician.

Take Our Peptide Plan Quiz →

References

Rahman MR, et al. Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging. PMC. 2024. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10917541/
Healthspan Research. Do NAD+ Boosters Work? What the Research Says About NR and NMN for Aging, Cognition & Muscle. 2025. Available from: https://www.gethealthspan.com/research/article/nad-boosters
Camacho-Pereira J, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through a SIRT3-Dependent Mechanism. Cell Metab. 2016;23(6):1127–1139. Available from: https://pubmed.ncbi.nlm.nih.gov/27304509/
Braidy N, et al. The use of a systems approach to increase NAD+ in human participants. npj Aging. 2024. Available from: https://www.nature.com/articles/s41514-023-00134-0
Orr ME, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024;46(1):665–682. Available from: https://pubmed.ncbi.nlm.nih.gov/37843646/
Morifuji M, et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults. GeroScience. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov
Dae-Goon Yoo, et al. Use of the Dietary Supplements NR and NMN to Increase NAD+, Impact Mitochondrial Function, and Improve Metabolic Health. MDPI. 2025. Available from: https://www.mdpi.com/3042-5158/1/2/9